Activity of venetoclax against relapsed acute undifferentiated leukemia.

Caldwell, Kenneth J; Budhraja, Amit; Opferman, Joseph T; Pui, Ching-Hon; Klco, Jeffery M; Rubnitz, Jeffrey E · Cancer · 2021

case_report · Level V

Where this comes from

Abstract

Acute undifferentiated leukemia is a rare hematologic malignancy with a poor prognosis. Venetoclax was highly active in two patients with relapsed acute undifferentiated leukemia and should be studied further.

Medical subject headings